Assessment of Antidiabetic Potential of Polyherbal Formulations

Simple item page
dc.contributor.authorAlimoddin, Mden_US
dc.contributor.authorAli, Waziden_US
dc.contributor.authorShafiuddin, Mohammeden_US
dc.contributor.authorAslam, Mohammaden_US
dc.contributor.authorKumar, Manishen_US
dc.date.accessioned2019-11-16T07:25:37Z
dc.date.available2019-11-16T07:25:37Z
dc.date.issued2016-07
dc.description.abstractIntroduction: Diabetes provides a major challenge to the present population globally. It is a major threat to global public health that is rapidly reaching epidemic scale. Plant based drugs are gaining importance to treat majority of human aliments including diabetes mellitus due to their less toxic effects. Aims: The present study was designed to assess the antidiabetic potential of polyherbal formulations in streptozotocin induced diabetic rats. Methods:  Diabetes was induced by single intraperitoneal injection of streptozotocin (50 mg/kg) in male Wistar rats. Rats with fasting blood glucose levels ≥ 250 mg/dl after seven days of STZ administration were randomized into different groups and were treated with Formulation-1 (F1) and Formulation-2 (F2) in graded doses for 21 days. At the end of the study, blood glucose, lipid profiles were estimated. In addition, enzymatic and non-enzymatic liver antioxidant levels were also estimated. To elucidate the mode of action, we evaluated its effects on oral glucose tolerance test in normal rats and single-dose one day-study and multiple-dose twenty one day- study in diabetic rats. Results:  The effect on the insulin level with the treatment by formulations suggests that the mode of action is a similar to that of Glibenclamide. Oral administration of F1 and F2 for 21 days significantly reduced blood glucose level in STZ induced diabetic rats. Both the formulations exhibited antihyperglycemic effect in glucose loaded rats and STZ induced rats. The blood glucose was significantly increased. Supplementation with F1 and F2 both with (250 and 500 mg/kg) showed reduction in the blood glucose levels and improved glucose tolerance, suggesting that there was an improvement in STZ-induced deleterious effects. Conclusion: This study reveals that F1 and F2 improved STZ-induced hyperglycemia, this effect may be mediated by interacting with multiple targets operating in diabetes mellitus.en_US
dc.identifier.affiliationsAssistant Professor, Department of Pharmacology, SVET College of Pharmacy Kallur road, Taluka Humnabad-585330 (Karnataka) India.en_US
dc.identifier.affiliationsPharmacovigilance Associate, PvPI, IPC Ghaziabad, MoH&FW, Govt. of India and posted at Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard University, New Delhi-110062, India.en_US
dc.identifier.affiliationsPharmacovigilance Associate, PvPI, IPC Ghaziabad, MoH&FW, Govt. of India and posted at Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard University, New Delhi-110062, India.en_US
dc.identifier.affiliationsQuality Inspector, Gulf Pharmaceutical Industries, airport road Dighdaga- 997, RAKen_US
dc.identifier.affiliationsSenior Analyst, National Dope testing Laboratory JLN Stadium, New Delhi -11000, India.en_US
dc.identifier.citationAlimoddin Md, Ali Wazid, Shafiuddin Mohammed, Aslam Mohammad, Kumar Manish. Assessment of Antidiabetic Potential of Polyherbal Formulations. International Archives of BioMedical and Clinical Research. 2016 Jul-Sep; 2(3): 84-88en_US
dc.identifier.issn2454-9894
dc.identifier.issn2454-9886
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/184324
dc.languageenen_US
dc.publisherIbn Sina Academy of Medieval Medicine & Sciencesen_US
dc.relation.issuenumber3en_US
dc.relation.volume2en_US
dc.source.urihttps://doi.org/10.21276//iabcr.2016.2.3.21en_US
dc.subjectStreptozotocin-diabetic ratsen_US
dc.subjectantihyperglycemicen_US
dc.subjectformulation-1en_US
dc.subjectformulation-2en_US
dc.titleAssessment of Antidiabetic Potential of Polyherbal Formulationsen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
iabcr2016v2n3p84.pdf
Size:
795.58 KB
Format:
Adobe Portable Document Format
Download
Collections
International Archives of BioMedical and Clinical Research